Health

UN Environment chief: We shouldn’t wait for the oceans to turn into a plastic swamp

At the latest United Nations environment summit, pollution topped the agenda. The man leading the UN’s quest to clean up the planet hopes this meeting will act as the wake-up call countries need and that the fight will include the world of business.

07-12-2017

Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped

Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive frameworks alive and well, Mark Alles told EURACTIV.com in an interview.

15-11-2017

Patients’ leader: Reimbursed anti-smoking programmes are a way to kill COPD

Stricter rules on smoking, reimbursed anti-smoking programmes and smoke-free public places are among the ways to prevent chronic obstructive pulmonary disease (COPD) from being a public health crisis, says Mikaela Odemyr.

14-11-2017

Kadenbach MEP: Tobacco warnings should mention chronic obstructive pulmonary disease

Progress has been made on tobacco products health warnings but the next round of graphic labelling should also mention the less-known chronic obstructive pulmonary disease (COPD), which happens to be the second cause of death worldwide, MEP Karin Kadenbach told EURACTIV.com.

 

12-10-2017

Vaccines boss: Clear privacy rules are needed for electronic immunisation record system

An electronic immunisation record system, which aims to better monitor vaccination among populations, will need clear privacy rules and individuals should be the owners of their own data, Patricia Massetti told EURACTIV.com in an interview. Patricia Massetti is an associate vice-president and European Vaccines Lead at MSD. She is also a Board member at Vaccines Europe, …

10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

04-10-2017

Gastein boss: Drugs access is ‘sensitive’ and cannot be viewed in isolation

Accessibility of medicines is a sensitive issue that must not be examined in isolation. Policymakers, academics, business and patients must be part of the discussion as well as “innovation” because access would not get the focus it needs without it, according to Dorli Kahr-Gottlieb.

Economy & Jobs 03-10-2017

Food expert: There is a link between poverty and unhealthy diets

Working class people are being harmed as companies abandon free lunch programs, according to food and health policy expert Dr Martin Caraher.

14-09-2017

Greek minister: EMA bid shows drugs are a social good

Athens’ decision to claim the European Medicine Agency's relocation from London sends a message that medicine is “not just a commodity but a social good”, Greece’s Alternate Minister of Foreign Affairs, Georgios Katrougalos, told EURACTIV.com.

Economy & Jobs 04-08-2017

Anti-monopolies economist: ‘Innovation breeds inequality’

Inequality is an inevitable side effect of innovation and many monopolies could be broken by simply eliminating patents, insists Italian economist Michele Boldrin. EURACTIV’s partner El País – Planeta Futuro reports.

Economy & Jobs 13-07-2017

Macron: Germany is competitive thanks to eurozone weaknesses

Ahead of Thursday’s (13 July) Franco-German Ministerial Council, Friday’s Bastille Day celebrations and Donald Trump’s visit to Paris, President Emmanuel Macron spoke to EURACTIV’s partner Ouest-France about Europe's future, and France’s relations with the US.

Endocrine disruptors: EU definition contains ‘too many exemptions and loopholes’

After years in the pipeline, an EU-wide definition of endocrine disruptors was finally approved by member states on 4 July. But MEP Pascal Durand told EURACTIV’s partner Ouest-France he is concerned the definition does not respect the precautionary principle.

11-07-2017

Dutch health minister: EMA relocation is not entertainment, listen to the Commission

The European Medicines Agency (EMA) is not a toy to be played with by politicians, Edith Schippers told EURACTIV.com. The decision on the agency's relocation should be based on the European Commission's assessment, she argues in an interview.

06-07-2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

Any country that wants to inherit the European Medicines Agency (EMA) from London has to be easily accessible. Candidates will also need to increase their national agency’s resources, as staff are expected to move to the EMA, according to Adrian van den Hoven.

Global Europe 28-06-2017

Mimica: We are analysing aid funding gaps left by the US

The EU is analysing the aid funding gap left by Donald Trump’s decision to ban US federal funding for NGOs providing birth control support or abortions in developing countries, Development Commissioner Neven Mimica told EURACTIV.com in an exclusive interview.

Development Policy 27-06-2017

SDG advocate: ‘Development projects cannot be designed in Brussels’

Development is not a one-way street, rather it is a dialogue, according to SDG advocate Dr Alaa Murabit. She told EURACTIV Germany that she supports the EU’s Consensus on Development but warned against making investment conditional.

24-05-2017

Andriukaitis: Anti-smoking laws are of little value if they are not implemented

Member states should prioritise laws that protect public health because there is little value in having them if they are not enforced, the EU's health Commissioner told EURACTIV.com in an interview.

Brexit 23-05-2017

Portuguese minister: Southern cities better placed to host medicines agency

Portugal is the latest member state to try and poach the UK-based European Medicines Agency after Brexit. In an interview with EURACTIV.com, Portugal’s junior minister for European affairs insisted having two EU agencies based in Lisbon already would not hurt its chances.

Development Policy 04-05-2017

African Union EU rep: ‘Africa shouldn’t just be a spectator to global decisions’

The African Unions EU representative, Ajay Bramdeo, told EURACTIV Germany that plans for a Marshall Plan for Africa are fundamentally good but warned that the continent needs to be the focus and that healthcare must be the priority.

07-04-2017

IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.

17-03-2017

Pharma boss: Some EU countries effectively delay market entry of generics

The harmonisation of different regulatory environments in the EU member states will help generic drugs enter the market, resulting in reduced prices for medicine and better patient access, Jacek Glinka told EURACTIV.com in an interview.

Agrifood 09-03-2017

Romanian MEP: EU needs food quality agency

Food quality in Western Europe can differ greatly to what Central and Eastern European shops stock on their shelves. S&D group MEP Daciana Sârbu spoke to EURACTIV Romania about the issue and promoting local produce.

22-02-2017

Greek pharma boss: Patients are punished when innovation is penalised

Patients are “punished” due to a lack of innovation-driven structural reforms in a crisis-hit public health system, the head of the Greek pharma industry said in an interview with Euractiv Greece.

08-02-2017

Andriukaitis: ‘Rare cancers present a particular challenge’

The European Commission’s priority when tackling rare cancers such as sarcomas is to ensure European Reference Networks (ERNS) are put in place so that all patients have access to the best expertise available in the EU, Vytenis Andriukaitis told Euractiv.com in an interview.